James Pan

Dr. Pan has over 20 years of experience in both small molecule and biologics drug discovery and development, research operation and management. He has successfully built and led discovery research teams and helped advance multiple research programs into the clinic.

Prior to joining Exacis, he was Vice President at The Centre for the Commercialization of Antibodies and Biologics in Toronto, Canada where he oversaw the entire preclinical pipeline and partnership programs. He served as Scientific Leader at The Toronto Recombinant Antibody Centre and as Staff Scientist and Head of Drug Discovery and Therapeutics at Campbell Family Institute for Breast Cancer Research, University Health Network in Canada.

Prior to this, he held various scientific and management positions at Affinium Pharmaceuticals and Genentech, Inc. Dr. Pan also co-founded several startup companies including ModMab Therapeutics, a recent spinout from University of Toronto.

He has extensive knowledge in cancer biology, immunology, cytokine and receptor signaling, pharmacology and animal models of disease as well as expertise in antibody and protein engineering. Dr. Pan obtained his PhD from University of Toronto and pursued post-doctoral training at both University of Toronto and University of Michigan.